Health
Study characterizes cisplatin-induced hearing loss in pediatric cancer patients – News-Medical.Net
Cisplatin is one of the most effective chemotherapy agents, used in just under half of pediatric cancer cases.
Cisplatin is one of the most effective chemotherapy agents, used in just under half of pediatric cancer cases. Permanent hearing loss is a common side effect of this medication, but until now, studies have been too small and too varied to accurately characterize this risk.
Today in The Lancet Child & Adolescent Health, investigators at Children’s Hospital Los Angeles published results of the largest study of cisplatin-induced hearing loss to date. The study establishes the first benchmarks for the…
-
Noosa News23 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Business24 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News21 hours agoCopperString transmission line projected to cost almost $14b amid massive blowout
-
Noosa News23 hours agoSXSW Sydney Has Announced the First 40 Speakers That’ll Be Taking to the Stage at Its 2025 Conference